News | December 08, 2009

First U.K. Patients Implanted With Coronary Bifurcation Stent

December 8, 2009 – The first live U.K. cases involving Cappella’s self-expanding Sideguard Coronary Sidebranch Stent and delivery system were recently performed at PCI Live 2009 with the second case following immediately thereafter, off-camera.

Dr. Joseph D. Mills, consultant cardiologist at the Liverpool Heart and Chest Hospital, U.K., performed both procedures. “We see numerous bifurcation cases and are very pleased to see that there is now a dedicated and straightforward solution to treating complex bifurcation lesions,” Dr. Mills said. “As the first centre in the U.K. to use Sideguard, we are very satisfied with the results.”

Cappella recently added an additional size of 3.25 mm to their current portfolio of 2.5 and 2.75 mm stents. This now enables treatment of bifurcation lesions in lumen diameters from 2.25 to 3.25 mm and lesion lengths less than or equal to 7 mm.

The Sideguard focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. It allows the preferred stent of choice for the main vessel. The stent offers an optimal design specific to the anatomy of the sidebranch, combined with the qualities of nitinol.

For more information: www.cappella-med.com, http://multivu.prnewswire.com/mnr/cappella/41383/

Related Content

FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Onyx DES 2.0 mm stent meets primary endpoints in small vessels
News | June 12, 2017
June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failur
First Pennsylvania Patient Treated in LEADERS FREE II Trial of BioFreedom Drug-Coated Stent
News | Stents Drug Eluting| May 12, 2017
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing the safety and...
Resolute Onyx DES, drug eluting stent, medtronic, gains FDA approval
Technology | Stents Drug Eluting| May 01, 2017
May 1, 2017 — The U.S.
Sponsored Content | Videos | Stents Drug Eluting| May 01, 2017
This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent.
Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation| March 31, 2017
Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was...
Sponsored Content | Videos | Stents Bioresorbable| March 30, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses t
Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral| March 16, 2017
W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular Stent, a...
Sponsored Content | Videos | Stents Bifurcation| March 06, 2017
This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent.
Overlay Init